NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Thursday that its revenues in the third quarter of 2009 fell 6 percent compared with the 2008 period, and that its net loss on the quarter was down 25 percent from the year-ago period.

The Omaha, Neb.-based genetic test provider said that it brought in revenues of $5 million for the three-month period ended Sept. 30, compared with $5.4 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.